A single-domain antibody detects and neutralises toxic Aβ42 oligomers in the Alzheimer’s disease CSF
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
A single-domain antibody detects and neutralises toxic Aβ42 oligomers in the Alzheimer’s disease CSF ; volume:16 ; number:1 ; day:18 ; month:1 ; year:2024 ; pages:1-19 ; date:12.2024
Alzheimer's research & therapy ; 16, Heft 1 (18.1.2024), 1-19, 12.2024
- Creator
-
Bigi, Alessandra
Napolitano, Liliana
Vadukul, Devkee M.
Chiti, Fabrizio
Cecchi, Cristina
Aprile, Francesco A.
Cascella, Roberta
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-023-01361-z
- URN
-
urn:nbn:de:101:1-2024033110274010280688
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bigi, Alessandra
- Napolitano, Liliana
- Vadukul, Devkee M.
- Chiti, Fabrizio
- Cecchi, Cristina
- Aprile, Francesco A.
- Cascella, Roberta
- SpringerLink (Online service)
Other Objects (12)
Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
Amyloid blood biomarker detects Alzheimer's disease
Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer’s disease
Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
CSF Presenilin-1 complexes are increased in Alzheimer’s disease
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
Alzheimer’s disease CSF biomarkers: clinical indications and rational use
Toxic epibatidine was structurally modified to image Alzheimer´s disease
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action
Prion protein oligomers cause neuronal cytoskeletal damage in rapidly progressive Alzheimer’s disease
Aβ oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in Alzheimer’s disease
Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease
Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
Amyloid blood biomarker detects Alzheimer's disease
Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer’s disease
Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
CSF Presenilin-1 complexes are increased in Alzheimer’s disease
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
Alzheimer’s disease CSF biomarkers: clinical indications and rational use
Toxic epibatidine was structurally modified to image Alzheimer´s disease
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action
Prion protein oligomers cause neuronal cytoskeletal damage in rapidly progressive Alzheimer’s disease
Aβ oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in Alzheimer’s disease
Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease
Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
Amyloid blood biomarker detects Alzheimer's disease
Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer’s disease
Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
CSF Presenilin-1 complexes are increased in Alzheimer’s disease
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
Alzheimer’s disease CSF biomarkers: clinical indications and rational use
Toxic epibatidine was structurally modified to image Alzheimer´s disease
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action
Prion protein oligomers cause neuronal cytoskeletal damage in rapidly progressive Alzheimer’s disease
Aβ oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in Alzheimer’s disease